| | | | Western blot - ADAMTS13 antibody - Propeptide domain (ab28275)  (enlarge) | |
| |
| Product Name | ADAMTS13 antibody - Propeptide domain |
| | See all ADAMTS13 antibodies (8)... |
| Product type | Primary antibodies |
| Description | Rabbit polyclonal to ADAMTS13 - Propeptide domain |
| Immunogen | Synthetic peptide based on the propeptide domain of human ADAMTS-13.(Peptide available as ab41248.) |
| Reacts with (species key) | Hu |
| Specificity | We have a range of domain specific antibodies for this target. For a full list please see all ADAMTS13 antibodies |
| Tested applications (see key) | WB |
|
| Abreviews | |
|
| Application notes (see key) | Recommended dilutions WB: 1/1000 - 1/5000. Detects a band of approximately 190 kDa (predicted molecular weight: 154 kDa). Glycosylation and the abundance of cysteine residues gives ADAMTS-13 an apparent molecular weight of 190 kDa on reduced SDS PAGE gels. Higher concentrations of antibody may be needed for samples from more distantly related species. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user. |
| Cellular localization | Secreted |
| Research areas | Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> ADAM TS Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> ADAM protein family Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> ADAM Protein Family |
| Relevance | ADAMTS13, also known as von Willebrands factor cleaving protease (vWFcp), was first identified by its ability to cleave the ultra large aggregates of vWF into smaller forms in the serum. A thrombocytopenic disorder called thrombic thrombocytopenic purpura (TTR) was shown to be due to a deficiency in the cleavage of von Willebrands factor, and ADAMTS13 was identified as the enzyme responsible. ADAMTS13 cleaves the Tyr1605 to Met1606 bond in the A2 domain of vWF, a process stimulated by shear stress in the circulation and by binding to either platelet glycoprotein IBa or to heparin. The cleaved vWF leads to decreased platelet adhesion. An idiopathic form of TTR is found in patients with auto antibodies to ADAMTS13. The full length ADAMTS-1 sequence codes for a 1,427 amino acid protein, with a predicted mass of 153.6 kDa, but glycosylation and the abundance of cysteine residues gives ADAMTS-13 an apparent molecular weight of about 190 kDa on reduced SDS PAGE gels. The variants reported include 1,371, 1,340 and 344 amino acids, with predicted mass of 130.3, 144.5 and 36.7 kDa respectively. Many bands of varying sizes can be seen on Western blots, between 110-190 kDa, perhaps indicating differentially processed ADAMTS-13. |
| | |
| Database links | The links below go to external sites and will open in a new browser window |
| Raised in | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Purity | Immunogen affinity purified |
| Storage buffer | Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
| Form | Liquid |
| Concentration | 1.000 mg/ml |
| Storage instructions | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles. |
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this ADAMTS13 antibody - Propeptide domain is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| See below for ADAMTS13 antibody - Propeptide domain images, references, products related to ab28275 and other tools. |
| |
ADAMTS13 antibody - Propeptide domain images: |
Western blot - ADAMTS13 antibody - Propeptide domain (ab28275) All lanes : ADAMTS13 antibody - Propeptide domain (ab28275) at 1 µg/ml
Lane 1 : Recombinant Human ATS-13 at 0.08 µg Lane 2 : Recombinant Human ATS-13 at 0.04 µg Lane 3 : Recombinant Human ATS-13 at 0.02 µg
Predicted band size : 154 kDa
Glycosylation and the abundance of cysteine residues gives ADAMTS-13 an apparent molecular weight of about 190 kDa on reduced SDS PAGE gels. |
| |
| |
| Search PubMed (MEDLINE) for references to ADAMTS13 |
| |
ADAMTS13 antibody - Propeptide domain - more information |
Customer reviews (feedback) regarding ADAMTS13 antibody - Propeptide domain |
Customer FAQs regarding ADAMTS13 antibody - Propeptide domain |
Protocols for ADAMTS13 antibody - Propeptide domain |
Price and availability of products related to ADAMTS13 antibody - Propeptide domain |
| |
ADAMTS13 antibody - Propeptide domain - related products: |
| |
| |
ADAMTS13 antibody - Propeptide domain - other tools: |
Contact Abcam with a Technical Enquiry about ADAMTS13 antibody - Propeptide domain |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"